Primary breast sarcoma: Case report and literature review

被引:0
作者
Khaoula, Magdoud [1 ,2 ,6 ]
Sirine, Bayar [3 ]
Sana, Menjli [3 ]
Eya, Azouz [4 ]
Ghada, Sahraoui [2 ,5 ]
Karima, Mrad [2 ,5 ]
机构
[1] Matern & Neonatol Ctr, Emergency Dept, Tunis, Tunisia
[2] Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
[3] Matern & Neonatol Ctr, Dept Gynecol, Tunis, Tunisia
[4] Rabta Hosp, Dept Radiol, Tunis, Tunisia
[5] Salah Azaiez Instate, Dept Histol, Sfax, Tunisia
[6] R534 F9H Rue Fac Med, Tunis, Tunisia
来源
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS | 2024年 / 119卷
关键词
Breast; Abscess; Sarcoma; Histology; Case report; Prognosis;
D O I
10.1016/j.ijscr.2024.109587
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Primary breast sarcoma (PBS), excluding phyllodes tumors, is an extremely rare and heterogeneous group of cancers, accounting for <1 % of all breast cancers. PBS is typically diagnosed in the fifth or sixth decades of life. There are no pathognomonic clinical or radiological features. Diagnosis is generally established through a microbiopsy. For young women, the diagnosis can be confused with a benign pathology. Clinical presentation: Our patient was 27 years old, with no family or personal history of breast cancer, which was initially brought to the emergency department with a breast abscess. The clinical diagnosis of abscessed mastitis was made. The patient underwent tissue excision with evacuation of blood clots and necrotic tissue. Histopathological examination revealed a primary breast sarcoma. An MRI showed locally advanced retro-glandular tumor. An abdominal and pelvic CT scan performed showed no evidence of secondary locations. Therefore, the patient was referred for neoadjuvant radiotherapy and chemotherapy. After the third course of chemotherapy, the patient died following cardiogenic shock. Discussion: The PBS in younger women is extremely rare. The etiopathogenesis remains undetermined. The clinical and radiological characteristics of PBS mimic breast adenocarcinoma. Mastectomy is the treatment of choice but in the case of locally advanced tumor, the use of neoadjuvant chemotherapy can be indicated. PBS presents a significantly poorer prognosis. Conclusion: Breast sarcomas are rare malignant tumors for which treatment protocols are not well-established. Further research efforts are needed to improve the understanding and treatment of PBS.
引用
收藏
页数:4
相关论文
共 20 条
  • [1] Primary and secondary breast angiosarcoma: single center report and a meta-analysis
    Abdou, Yara
    Elkhanany, Ahmed
    Attwood, Kristopher
    Ji, Wenyan
    Takabe, Kazuaki
    Opyrchal, Mateusz
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 523 - 533
  • [2] Diagnosis and management of primary breast sarcoma
    Al-Benna, Sammy
    Poggemann, Kerstin
    Steinau, Hans-Ulrich
    Steinstraesser, Lars
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (03) : 619 - 626
  • [3] Al-Wiswasy Mohammad, 2021, Breast Dis, V40, P199, DOI 10.3233/BD-201012
  • [4] Relative frequency and morphology of cancers in carriers of germline TP53 mutations
    Birch, JM
    Alston, RD
    McNally, RJQ
    Evans, DGR
    Kelsey, AM
    Harris, M
    Eden, OB
    Varley, JM
    [J]. ONCOGENE, 2001, 20 (34) : 4621 - 4628
  • [5] The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database
    Cates, Justin M. M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (02): : 144 - 152
  • [6] Sarcomas of the Breast
    Duncan, Mallory A.
    Lautner, Meeghan A.
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (04) : 869 - +
  • [7] Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast
    Gutnik, Lily
    Ren, Yi
    Thomas, Samantha M.
    Plichta, Jennifer K.
    Greenup, Rachel A.
    Fayanju, Oluwadamilola M.
    Hwang, E. Shelley
    Rosenberger, Laura H.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (06) : 947 - 957
  • [8] Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma The EORTC 62961-ESHO 95 Randomized Clinical Trial
    Issels, Rolf D.
    Lindner, Lars H.
    Verweij, Jaap
    Wessalowski, Rudiger
    Reichardt, Peter
    Wust, Peter
    Ghadjar, Pirus
    Hohenberger, Peter
    Angele, Martin
    Salat, Christoph
    Vujaskovic, Zeljko
    Daugaard, Soeren
    Mella, Olav
    Mansmann, Ulrich
    Durr, Hans Roland
    Knosel, Thomas
    Abdel-Rahman, Sultan
    Schmidt, Michael
    Hiddemann, Wolfgang
    Jauch, Karl-Walter
    Belka, Claus
    Gronchi, Alessandro
    [J]. JAMA ONCOLOGY, 2018, 4 (04) : 483 - 492
  • [9] Karlin N.J., 2018, BREAST COMPR MANAG B, P156, DOI [10.1016/b978-0-323-35955-9.00011-8, DOI 10.1016/B978-0-323-35955-9.00011-8, 10.1016/B978-0-323-35955-9.00011-8]
  • [10] Chemotherapy and targeted treatments of breast sarcoma by histologic subtype
    Kokkali, Stefania
    Stravodimou, Athina
    Duran-Moreno, Jose
    Koufopoulos, Nektarios
    Voutsadakis, Ioannis A.
    Digklia, Antonia
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (06) : 591 - 604